TRIATET Trademark

Trademark Overview

On Tuesday, April 19, 2022, a trademark application was filed for TRIATET with the United States Patent and Trademark Office. The USPTO has given the TRIATET trademark a serial number of 97370046. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, April 3, 2024. This trademark is owned by TEVA PHARMACEUTICALS USA, Inc.. The TRIATET trademark is filed in the Pharmaceutical Products category with the following description:

Antiretroviral drug for the treatment of HIV-1 infection in adults
triatet

General Information

Serial Number97370046
Word MarkTRIATET
Filing DateTuesday, April 19, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, April 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 28, 2023

Trademark Statements

Goods and ServicesAntiretroviral drug for the treatment of HIV-1 infection in adults

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 25, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameTEVA PHARMACEUTICALS USA, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Thursday, April 4, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 3, 2024SOU EXTENSION 2 GRANTED
Wednesday, April 3, 2024SOU EXTENSION 2 FILED
Wednesday, April 3, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 16, 2023SOU EXTENSION 1 GRANTED
Wednesday, August 16, 2023SOU EXTENSION 1 FILED
Wednesday, August 16, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, April 25, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 28, 2023PUBLISHED FOR OPPOSITION
Wednesday, February 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, February 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 2, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, February 2, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 2, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 25, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 24, 2023ASSIGNED TO EXAMINER
Thursday, July 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, April 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 22, 2022NEW APPLICATION ENTERED

Related Keywords

triatet adults infection treatment drug antiretroviral